Scarica l'app Stockscreener
9.94
14.24%
-1.65
Dopo l'orario di chiusura:
9.94
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché AVDL Giù?
Forum
Previsione
Precedente Chiudi:
$11.59
Aprire:
$11.3
Volume 24 ore:
4.24M
Relative Volume:
3.63
Capitalizzazione di mercato:
$957.83M
Reddito:
$47.56M
Utile/perdita netta:
$-156.83M
Rapporto P/E:
-4.7788
EPS:
-2.08
Flusso di cassa netto:
$-127.98M
1 W Prestazione:
-10.85%
1M Prestazione:
-33.95%
6M Prestazione:
-36.53%
1 anno Prestazione:
-20.67%
Intervallo 1D:
$9.41
$11.44
Intervallo di 1 settimana:
$9.41
$11.66
Portata 52W:
$9.41
$19.09
Avadel Pharmaceuticals Plc Stock (AVDL) Company Profile
Nome
Avadel Pharmaceuticals Plc
Settore
Telefono
636-449-1830
Indirizzo
BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK, DUBLIN
Confronta AVDL con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
AVDL
Avadel Pharmaceuticals Plc
|
9.94 | 957.83M | 47.56M | -156.83M | -127.98M | -1.83 |
|
ZTS
Zoetis Inc
|
176.94 | 79.24B | 9.15B | 2.43B | 2.31B | 5.32 |
|
TAK
Takeda Pharmaceutical Co Adr
|
13.92 | 43.58B | 30.27B | 1.93B | 3.45B | 0.6044 |
|
HLN
Haleon Plc Adr
|
9.71 | 43.54B | 14.26B | 1.55B | 0 | 0.3383 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
17.53 | 19.58B | 16.77B | -959.00M | 1.37B | -0.85 |
|
VTRS
Viatris Inc
|
13.00 | 15.64B | 15.05B | -883.30M | 1.89B | -0.74 |
Avadel Pharmaceuticals Plc Stock (AVDL) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-06-12 | Iniziato | Rodman & Renshaw | Buy |
| 2024-03-05 | Reiterato | H.C. Wainwright | Buy |
| 2024-03-05 | Reiterato | Needham | Buy |
| 2024-03-05 | Reiterato | Oppenheimer | Outperform |
| 2024-02-06 | Iniziato | UBS | Buy |
| 2022-11-30 | Aggiornamento | Jefferies | Hold → Buy |
| 2022-08-10 | Downgrade | Jefferies | Buy → Hold |
| 2022-07-28 | Ripresa | Craig Hallum | Buy |
| 2022-05-26 | Downgrade | Stifel | Buy → Hold |
| 2021-09-23 | Iniziato | Needham | Buy |
| 2020-07-31 | Iniziato | Oppenheimer | Outperform |
| 2020-07-21 | Iniziato | SVB Leerink | Outperform |
| 2020-06-30 | Iniziato | H.C. Wainwright | Buy |
| 2020-04-03 | Iniziato | Jefferies | Buy |
| 2020-03-12 | Iniziato | Stifel | Buy |
| 2020-02-26 | Iniziato | Piper Sandler | Overweight |
| 2020-01-30 | Iniziato | Craig Hallum | Buy |
| 2019-06-14 | Aggiornamento | Ladenburg Thalmann | Neutral → Buy |
| 2019-02-08 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
Mostra tutto
Avadel Pharmaceuticals Plc Borsa (AVDL) Ultime notizie
Avadel Pharmaceuticals sees shares drop after CCO resignation By Investing.com - Investing.com Nigeria
Avadel Pharmaceuticals announces CCO resignation - Investing.com
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Receives Average Recommendation of "Buy" from Brokerages - MarketBeat
Avadel Pharmaceuticals PLC (AVDL) Shares Up 3.53% on Dec 2 - GuruFocus.com
Where are the Opportunities in (AVDL) - Stock Traders Daily
The Price Is Right For Avadel Pharmaceuticals plc (NASDAQ:AVDL) Even After Diving 27% - Simply Wall St
Braidwell LP Grows Holdings in Avadel Pharmaceuticals plc (NASDAQ:AVDL) - MarketBeat
Avadel Pharmaceuticals: Despite My Sympathies For The Company, Stock Looks Risky (AVDL) - Seeking Alpha
Avadel Pharmaceuticals PLC (AVDL) Shares Up 3% on Nov 22 - GuruFocus.com
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Short Interest Down 7.3% in October - MarketBeat
What is HC Wainwright’s Estimate for AVDL FY2024 Earnings? - Defense World
Idiopathic Hypersomnia Treatment Market will experience - openPR
HC Wainwright Issues Pessimistic Forecast for AVDL Earnings - MarketBeat
What is Lifesci Capital's Forecast for AVDL FY2024 Earnings? - MarketBeat
What is Leerink Partnrs' Forecast for AVDL FY2024 Earnings? - MarketBeat
Avadel Pharmaceuticals plc (AVDL) Outlook: Looking Back For Insights - Stocks Register
Janus Henderson Group's Strategic Acquisition of Avadel Pharmace - GuruFocus.com
FY2025 Earnings Estimate for AVDL Issued By Leerink Partnrs - MarketBeat
Avadel Pharmaceuticals Third Quarter 2024 Earnings: Beats Expectations - Yahoo Finance UK
Avadel Pharmaceuticals plc (AVDL) Quarterly 10-Q Report - Quartz
Avadel shares price target cut, maintains buy on Q3 results By Investing.com - Investing.com Nigeria
Polar Capital Holdings Plc's Strategic Reduction in Avadel Pharm - GuruFocus.com
Avadel Pharmaceuticals PLC (AVDL) Shares Down 7.38% on Nov 13 - GuruFocus.com
Avadel Pharmaceuticals (NASDAQ:AVDL) Announces Earnings Results - MarketBeat
Avadel Pharmaceuticals (NASDAQ:AVDL) Stock Price Down 3.9% After Analyst Downgrade - MarketBeat
HC Wainwright Has Lowered Expectations for Avadel Pharmaceuticals (NASDAQ:AVDL) Stock Price - MarketBeat
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Q3 2024 Earnings Call Transcript - Insider Monkey
Avadel Pharmaceuticals to Present at the Jefferies London Healthcare Conference - The Manila Times
Avadel Pharmaceuticals to Present at Jefferies London Healthcare Conference | AVDL Stock News - StockTitan
Avadel Pharmaceuticals Reports Strong Growth with LUMRYZ - TipRanks
Avadel: Q3 Earnings Snapshot - Houston Chronicle
Avadel Pharmaceuticals PLC (AVDL) Stock Price Down 15.83% on Nov 12 - GuruFocus.com
Avadel Pharmaceuticals plc Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Needham & Company LLC Reiterates Buy Rating for Avadel Pharmaceuticals (NASDAQ:AVDL) - MarketBeat
Avadel Pharmaceuticals Provides Corporate Update and Reports Third Quarter 2024 Financial Results - The Manila Times
Avadel's LUMRYZ Sales Surge to $50M as Patient Base Grows 44% in Q3 | AVDL Stock News - StockTitan
Avadel Pharmaceuticals PLC (AVDL) Q3 2024: Everything You Need To Know Ahead Of Earnings - Yahoo Finance
Learn to Evaluate (AVDL) using the Charts - Stock Traders Daily
Avadel Pharmaceuticals plc (NASDAQ:AVDL) Given Consensus Recommendation of "Buy" by Analysts - MarketBeat
Avadel Pharmaceuticals (AVDL) Scheduled to Post Quarterly Earnings on Tuesday - MarketBeat
Avadel Pharmaceuticals to Provide a Corporate Update and Report Third Quarter 2024 Financial Results on November 12 - The Manila Times
Avadel Pharmaceuticals (NASDAQ:AVDL) Earns “Buy” Rating from Needham & Company LLC - Defense World
Oppenheimer Forecasts Strong Price Appreciation for Avadel Pharmaceuticals (NASDAQ:AVDL) Stock - Defense World
Avadel Pharmaceuticals’ (AVDL) “Buy” Rating Reaffirmed at HC Wainwright - Defense World
Court Denies Jazz’s Challenge of Avadel’s Orphan Drug Lumryz - Sleep Review
US court upholds Avadel’s narcolepsy drug approval amid exclusivity battle - Yahoo Finance
Loss-Making Avadel Pharmaceuticals plc (NASDAQ:AVDL) Expected To Breakeven In The Medium-Term - Yahoo Finance
Avadel Pharmaceuticals Sees Unusually High Options Volume (NASDAQ:AVDL) - Defense World
Court upholds FDA approval of Avadel's narcolepsy drug LUMRYZ By Investing.com - Investing.com South Africa
Avadel Pharmaceuticals (NASDAQ:AVDL) Shares Gap UpStill a Buy? - MarketBeat
Court upholds FDA approval of Avadel's narcolepsy drug LUMRYZ - Investing.com
Avadel Pharmaceuticals Plc Azioni (AVDL) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.19%
0.44%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):